5 Lifesaving Technologies You Can Work on Today at Johnson & Johnson
re you looking for a career that allows you to touch—and maybe even save—countless lives through cutting-edge innovations in healthcare? Do you want to work with other ambitious professionals who are dedicated to using the latest technologies to change the trajectory of healthcare around the world?
We might have just the role for you. Here are five lifesaving technologies you can contribute to at Johnson & Johnson—starting today.
3-D printing is revolutionizing everything from manufacturing to archaeology—and even criminal investigations. At Johnson & Johnson, we’re using it to create innovative healthcare technologies. That’s why we created our 3-D Printing Center of Excellence, which is working to change the landscape of healthcare through 3-D printing solutions that are tailor-made to individual patients.
DePuy Synthes and Ethicon, two members of our family of companies, have also been working on revolutionary products of their own. With 3-D printing technology, they’ve created a prototype for bioprinted knee meniscus tissue with the idea of making surgery and recovery quicker, more efficient and less painful for patients. Our companies are also working on ways to make sure patients are following their treatment plans through medication tablets with sensors (3-D printed, of course) that can send notifications to doctors and caregivers to let them know when the pill has been ingested.
Our 3-D printing innovations also include customized surgical tools. When surgeons enter the operating room, they carry multiple sets of surgical tools in different sizes. It’s the classic one-size-doesn’t-fit-all problem. But through 3-D printing, we’ve been working to customize these instruments specifically for each patient.
A treatment process that could stop cancer before it wreaks havoc on the body would be nothing short of astounding. The Hematology and Oncology Department at Janssen Research & Development, another member of our family, is working toward doing exactly that.
The idea behind it is this: When cancer takes hold, it becomes complex and more resistant to treatments. But before that, the disease tends to develop slowly over a number of years and is often preceded by premalignant cells that are usually easier to treat. As the team’s theory goes, finding these premalignant cells and targeting them provides the best shot at possibly curing cancer.
The team at Janssen has already had successful interceptions in cases of both colon cancer and a form of blood cancer called multiple myeloma, and continues to test the efficacy of the process.
Digital Surgery Platform
Two years ago, we partnered with the formerly Google-owned Verily Life Sciences to create Verb Surgical, with the goal of creating a comprehensive surgical solutions platform that can help advance the field of robot-assisted surgery.
Earlier in 2017, the group unveiled a prototype that perfectly marries our healthcare know-how with the tech-savvy nature of a former Google-backed venture. The prototype was a digital surgery platform—or what Verb Surgical CEO Scott Huennekens calls “Surgery 4.0”— that combines robotics, artificial intelligence and data analytics. As the new development progresses, Verb Surgical hopes to increase access to minimally invasive surgery, achieve greater hospital efficiency and enable better patient outcomes.
There’s an app for just about everything these days, and when it comes to diabetes monitoring, there’s an app for that, too. As part of our commitment to advancing human-centered technology, we’ve recently released the OneTouch Reveal® mobile app.
When patients use a OneTouch Verio Flex® blood glucose meter with its embedded Bluetooth wireless communication, they can visualize trends in their numbers with a timeline of important blood sugar events that highlights when they’ve been repeatedly out of range. Patients can even share their results with their families, friends and doctors.
Hacking the Microbiome
The microbiome is the collection of bacteria and other microorganisms that naturally reside within and on each and every human. We’ve witnessed so much importance in studying and harnessing its potential that we’ve founded the first institute dedicated to its study: the Janssen Human Microbiome Institute (JHMI).
JHMI’s work spans a wide range of scientific inquiry—from microbiome-based digital diagnostic tools to sophisticated cocktails of microorganisms to treat disease. One of the group’s most fascinating and promising projects is Mosaic, a cloud-based microbiome informatics platform that provides a “secure and collaborative space where researchers can develop, improve, compare and share microbiome research methods.” JHMI researchers create specific challenges on the platform designed to encourage community-driven research that can inform and influence future product development.
These are just a few of the countless cutting-edge, lifesaving projects you can work on here at Johnson & Johnson. We’ve got plenty of open roles where people like you can make a positive contribution immediately. If you’re ready to find a challenging, rewarding career that allows you to make a measurable, positive impact on the world, we’d love to meet you. Apply today.